Our adept speaking faculty will arm you with proven strategies to facilitate benefit-risk counseling, optimize REMS operations through streamlined health system integration, leverage interoperable ...

showcased a presentation by CEO Dr. Uma Sharma at the REMS (risk evaluation and mitigation strategies) Industry Consortium Annual Meeting in Arlington, Virginia. The integration of proprietary ...

Most physician prescribers were satisfied with the FDA's controversial risk evaluation and mitigation strategy (REMS) program for clozapine, survey data showed. Among 196 doctors who prescribed ...

Idorsia Ltd (SIX: IDIA) today announced that – effective immediately – the US FDA has fully released TRYVIO™ (aprocitentan) from its REMS (Risk Evaluation and Mitigation Strategy ...

This drug is available only under a Risk Evaluation and Mitigation Strategy (REMS). For drugs that come with serious safety risks, a REMS informs prescribers and patients about the risks and sets ...

Approved last year for patients with hypertension currently not controlled on other blood pressure-lowering agents, the drug previously was only available in the US through the FDA’s risk evaluation ...

The FDA still recommends prescribers monitor patients’ ANC levels according to the prescribing information. The Food and Drug Administration (FDA) has removed the risk evaluation and mitigation ...

Vanrafia can be seamlessly added to supportive care in IgAN and used as a foundational therapy with no requirement for a REMS (Risk Evaluation Mitigation Strategy) program 1 Phase III data showed ...